跳至主要内容
临床试验/CTRI/2025/03/083747
CTRI/2025/03/083747尚未招募不适用

PREVALENCE AND CLINICO PATHOLOGICAL PROFILE OF IgA NEPHROPATHY IN A TERITIARY CARE HOSPITAL IN CENTRAL INDIA

未提供1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年4月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
To determine the prevalence of IgA nephropathy from a

研究概览

简要总结

A study conducted in a rural tertiary care hospital in Central India aiming to investigate  the prevalence and clinic pathological profile of IgA nephropathy (IgAN) patients. The rationale behind the study is to assess cost-effective investigations for diagnosing  and potentially improving patient outcomes. The study design is a cross-sectional study with a duration of 24 months, conducted at Acharya Vinoba Bhave Rural Hospital. The sample size is determined to be 100 patients meeting specific inclusion criteria. Data collection involves obtaining baseline demographic and clinical data, including age, gender, BMI, and blood pressure, and analyzing serum samples for various biochemical markers. Ethical considerations, including patient confidentiality and informed consent, are emphasized. The primary outcome is to determine the prevalence of IgA nephropathy from a tertiary care hospital in central India.. The abstract highlights the study’s potential contributions to IgAN clinicopathological profile and management in the rural Indian population.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • 1.All patients of age more than 18 years diagnosed to have IgAN and on regular follow up.
  • All patients with IgAN on maintenance hemodialysis.
  • All newly diagnosed patients with IgAN.
  • All patients presenting to nephrology OPD with renal biopsy proven IgAN or willing for renal biopsy to be done in the department of nephrology in the past 4 yrs.

排除标准

  • 1.All patients with age less than 18 yrs.
  • All patients with psychosocial illness or condition that may curtail their ability to consent or fulfill inclusion criteria no :
  • All patients with systemic lupus erythematosis, henoch scholein purpura or liver disease.

结局指标

主要结局

To determine the prevalence of IgA nephropathy from a

时间窗: baseline

tertiary care hospital in central India

时间窗: baseline

次要结局

  • 1.To determine the varied symptoms/ syndromic(presentation of IgAN .)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Vijay Jeyachandran

Datta Meghe Institute of Higher Education and Research

研究点 (1)

Loading locations...

相似试验